HLA DQ/DR Genetic Studies

The HLA DR/DQ gene analyses two important genomic markers called HLA-DQB1 and HLA-DR that can reveal important information relating to autoimmune disorders as well as inflammatory disorders. It is said that approximately 25% of the world’s population have one of the 10 susceptible types of HLA DR/DQ genes.

The HLA DR/DQ gene test shows haplotypes (gene combinations) which show susceptibility to mould, Lyme and conditions. The report contains a Rosetta Stone, developed by Dr. Ritchie Shoemaker which offers a summary of the various susceptible genetic types, with directions for interpretation.

Test details

• Test code: 3401
• Category: Environmental
• Kit requirements: EDTA
• Collection method: CI05.22.01
• Test method: PCR genotyping
• Turnaround time: 12-15 Business Days

What is measured

• HLA-DQB1
• HLA-DR

Resources

• Patient Brochure
• Sample Report

This test should be ordered and interpreted with guidance from a qualified healthcare practitioner.

Important: Test information is general only. Results should be interpreted with a qualified health practitioner and do not replace medical advice or diagnosis.